The BioInsights Podcast

The Maryland Stem Cell Research Fund (MSCRF) is a well-established US state fund aimed specifically at driving the development of new medical strategies for the prevention, diagnosis, treatment and cure of human diseases, injuries, and conditions through human stem cells. Here, we discuss the MSCRF’s specific activities and goals with Executive Director, Dr Amrithar Jaishankar, and get her take on...

Transient transfection of plasmids into suspension HEK293 cells is still the most commonly used method for the production of recombinant adeno-associated virus (rAAV) gene therapies – in this episode, Diane Golebiowski and Marissa Stanvick discuss ways to optimize that process. 

Welcome to a 2-part series in which we identify and distill some key learnings for partnering success in today's life sciences sector. Perhaps one of the most valuable take-aways from the COVID-19 pandemic response is the sheer scale of what may be achieved through effective collaboration. Over the next three episodes, we'll talk to a range of different stakeholders from across BioInsigh...

PART 1: The Big Pharma Perspective Welcome to a 2-part series in which we identify and distill some key learnings for partnering success in today's life sciences sector. Perhaps one of the most valuable take-aways from the COVID-19 pandemic response is the sheer scale of what may be achieved through effective collaboration. Over the next three episodes, we'll talk to a range of different...

PART 3: Innovation in staff sourcing, training and retention - what works and what doesn’t? Welcome to a 4-part series exploring a question that the entire cell and gene therapy community is struggling with at the moment: “Where will tomorrow’s workforce come from?” The cell and gene therapy field has been advancing at a breakneck speed for the best part of a decade now, fuelled by long-awaited cl...

PART 4: Who are tomorrow’s cell and gene therapy workers? Welcome to a 4-part series exploring a question that the entire cell and gene therapy community is struggling with at the moment: “Where will tomorrow’s workforce come from?” The cell and gene therapy field has been advancing at a breakneck speed for the best part of a decade now, fuelled by long-awaited clinical successes, commercial break...

Part 2: How is the educational system responding, and how can the cell and gene therapy community at large help? Welcome to a four-part series exploring a question that the entire cell and gene therapy community is struggling with at the moment: “Where will tomorrow’s workforce come from?” The cell and gene therapy field has been advancing at a breakneck speed for the best part of a decade, fuelle...

Welcome to a 4-part series exploring a question that the entire cell and gene therapy community is struggling with at the moment: “Where will tomorrow’s workforce come from?” The cell and gene therapy field has been advancing at a breakneck speed for the best part of a decade, fuelled by long-awaited clinical successes, commercial breakthroughs, and a related startling increase in activity from bo...

Ratish Krishnan and Oliver Rammo share their thoughts on the need for a more nuanced understanding of AAV capture and empty–full separation, and the trends driving innovation in this area.

In this episode Ilaria Scarfone Field Application Specialist, Pharma Analytics, Thermo Fisher Scientific speaks to Mike Brewer, Director and Global Principal Consultant, BioProduction Division, Thermo Fisher Scientific about the challenges for residual DNA testing in viral vector manufacture. To read this interview and access lots more content, visit the Cell and Gene Therapy Insights website.

In this Episode, Roisin McGuigan, Editor at BioInsights, speaks to Dr Barbara Fisher, Process Consultant at Single Use Support about automating aseptic filling for lowest volumes. Barbara works with both established pharmaceutical manufacturers and start-up companies, and has in-depth expedience in low bioburden and aseptic GMP manufacturing from downstream processing to fill and finish.  To read...